On the contrary, we have observed an upregulation of inflammation promoting mediators (e.g., NF-kB, AKT) and inflammatory cytokines (e.g., IL23 that enhances expansion of Th17 cells) only in patients with RA [Fig. 4]. This evidence concerns the gene NFKB1 and rheumatoid arthritis.